RhondaLBittingMD
Oncology • Winston Salem, NCGenitourinary Oncology
Medical Oncologist, Durham VA Healthcare System
Dr. Bitting is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Center Blvd Hematology and Oncology
Winston Salem, NC 27157Phone+1 336-716-0327
Summary
- Dr. Rhonda Bitting is an oncologist in Winston Salem, NC and is affiliated with Wake Forest Baptist Medical Center. She received her medical degree from Vanderbilt University School of Medicine and has been in practice 12 years. She specializes in genitourinary oncology and is experienced treating prostate, bladder, kidney and testicular cancers.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012
University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
Vanderbilt University School of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2009 - 2025
CA State Medical License 2006 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) Start of enrollment: 2014 Apr 01
- Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer Start of enrollment: 2016 Apr 06
- Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer Start of enrollment: 2017 Feb 22
- Join now to see all
Publications & Presentations
PubMed
- Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.Evan Y Yu, R Bryan Rumble, Neeraj Agarwal, Heather H Cheng, Scott E Eggener
Journal of Clinical Oncology. 2025-02-20 - Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study.Alexander R Lucas, Dustin Bastiach, Bassam Dahman, Asit K Paul, Samina Hirani
Cardio-Oncology. 2025-02-06 - Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review.Amir Alishahi Tabriz, Matthew J Boyer, Adelaide M Gordon, David J Carpenter, Jeffrey R Gingrich
Annals of Internal Medicine. 2025-01-21
Press Mentions
Veracyte Announces That Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate CancerAugust 23rd, 2023- Analysis Group Researchers Identify Racial Disparities in Treatment of Metastatic Castration-Sensitive Prostate CancerApril 19th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
